400 related articles for article (PubMed ID: 23765698)
41. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
Kamperis K; Hagstroem S; Faerch M; Mahler B; Rittig S; Djurhuus JC
Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
[TBL] [Abstract][Full Text] [Related]
42. Urinary incontinence in children.
Schultz-Lampel D; Steuber C; Hoyer PF; Bachmann CJ; Marschall-Kehrel D; Bachmann H
Dtsch Arztebl Int; 2011 Sep; 108(37):613-20. PubMed ID: 21977217
[TBL] [Abstract][Full Text] [Related]
43. The pathophysiology of monosymptomatic nocturnal enuresis with special emphasis on the circadian rhythm of renal physiology.
Dossche L; Walle JV; Van Herzeele C
Eur J Pediatr; 2016 Jun; 175(6):747-54. PubMed ID: 27138767
[TBL] [Abstract][Full Text] [Related]
44. Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.
Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle C; Vansintjan P; Donckerwolcke R; Vande Walle J
J Urol; 2007 Sep; 178(3 Pt 1):1048-51; discussion 1051-2. PubMed ID: 17632162
[TBL] [Abstract][Full Text] [Related]
45. Randomized comparison of long-term desmopressin and alarm treatment for bedwetting.
Evans J; Malmsten B; Maddocks A; Popli HS; Lottmann H;
J Pediatr Urol; 2011 Feb; 7(1):21-9. PubMed ID: 20579938
[TBL] [Abstract][Full Text] [Related]
46. Can the combined treatment of solifenacin and imipramine has a role in desmopressin refractory monosymptomatic nocturnal enuresis? A prospective double-blind randomized placebo-controlled study.
Samir M; Mahmoud MA; Elawady H
Urologia; 2021 Nov; 88(4):369-373. PubMed ID: 33568005
[TBL] [Abstract][Full Text] [Related]
47. The Relationship Between Nocturnal Enuresis and Spina Bifida Occulta: A Prospective Controlled Trial.
Yavuz A; Bayar G; Kilinc MF; Sariogullari U
Urology; 2018 Oct; 120():216-221. PubMed ID: 30099128
[TBL] [Abstract][Full Text] [Related]
48. Reboxetine in therapy-resistant enuresis: a retrospective evaluation.
Lundmark E; Nevéus T
Scand J Urol Nephrol; 2009; 43(5):365-8. PubMed ID: 19921980
[TBL] [Abstract][Full Text] [Related]
49. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
50. The efficacy of alarm therapy versus desmopressin therapy in the treatment of primary mono-symptomatic nocturnal enuresis: a systematic review.
Perrin N; Sayer L; While A
Prim Health Care Res Dev; 2015 Jan; 16(1):21-31. PubMed ID: 24252606
[TBL] [Abstract][Full Text] [Related]
51. Primary monosymptomatic nocturnal enuresis in children and adolescents.
Lottmann HB; Alova I
Int J Clin Pract Suppl; 2007 Sep; (155):8-16. PubMed ID: 17727574
[TBL] [Abstract][Full Text] [Related]
52. Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis.
Song P; Huang C; Wang Y; Wang Q; Zhu W; Yue Y; Wang W; Feng J; He X; Cui L; Wan T; Wen J
BJU Int; 2019 Mar; 123(3):388-400. PubMed ID: 30216627
[TBL] [Abstract][Full Text] [Related]
53. [The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis].
Korzeniecka-Kozerska A; Zoch-Zwierz W; Wasilewska A; Porowski T
Pol Merkur Lekarski; 2008; 24 Suppl 4():56-60. PubMed ID: 18924504
[TBL] [Abstract][Full Text] [Related]
54. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
55. Clinical management of nocturnal enuresis.
Kuwertz-Bröking E; von Gontard A
Pediatr Nephrol; 2018 Jul; 33(7):1145-1154. PubMed ID: 28828529
[TBL] [Abstract][Full Text] [Related]
56. Primary and Secondary Enuresis: Pathophysiology, Diagnosis, and Treatment.
Haid B; Tekgül S
Eur Urol Focus; 2017 Apr; 3(2-3):198-206. PubMed ID: 28888814
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
Ezodin N; Sarouei M; Khademlo M; Milani SH; Yousefi S; Mohammadjafari H
Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
[TBL] [Abstract][Full Text] [Related]
58. [Results of a therapeutic strategy against monosymptomatic nocturnal enuresis].
Rodríguez do Forno A; Ariceta Iraola G
An Esp Pediatr; 2001 Jan; 54(1):38-43. PubMed ID: 11181193
[TBL] [Abstract][Full Text] [Related]
59. [Drug therapy of enuresis].
von Gontard A; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 1996 Mar; 24(1):18-33. PubMed ID: 9459680
[No Abstract] [Full Text] [Related]
60. [Primary enuresis -- combination therapy with oxybutynin plus desmopressin shows good results].
Brudermanns B
Aktuelle Urol; 2007 Mar; 38(2):86-8. PubMed ID: 17390271
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
